These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2451040

  • 1. Aromatase inhibition in the dog. II. Effect on growth, function, and pathology of the prostate.
    Oesterling JE, Juniewicz PE, Walters JR, Strandberg JD, Steele RE, Ewing LL, Coffey DS.
    J Urol; 1988 Apr; 139(4):832-9. PubMed ID: 2451040
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of inhibition of aromatase enzyme activity on Leydig cell number and ultrastructure in beagles.
    Walters JR, Juniewicz PE, Oesterling JE, Mendis-Handagama SM, Zirkin BR, Ewing LL.
    Endocrinology; 1988 Nov; 123(5):2223-9. PubMed ID: 2971525
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of aromatase with CGS 16949A in postmenopausal women.
    Santen RJ, Demers LM, Adlercreutz H, Harvey H, Santner S, Sanders S, Lipton A.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):99-106. PubMed ID: 2521224
    [Abstract] [Full Text] [Related]

  • 7. Effects of the nonsteroidal aromatase inhibitor, Fadrozole, on sexual behavior in male rats.
    Bonsall RW, Clancy AN, Michael RP.
    Horm Behav; 1992 Jun; 26(2):240-54. PubMed ID: 1535332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro.
    Lamberts SW, Bruining HA, Marzouk H, Zuiderwijk J, Uitterlinden P, Blijd JJ, Hackeng WH, De Jong FH.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):896-901. PubMed ID: 2550511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.
    Steele RE, Mellor LB, Sawyer WK, Wasvary JM, Browne LJ.
    Steroids; 1987 Oct; 50(1-3):147-61. PubMed ID: 2973160
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y, Sugamata N, Owada S, Tago T, Sato H, Yokoe T, Maemura M, Morishita Y, Horiuchi R.
    Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC, Ewing LL, Niswender GD.
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
    Nishino Y, Schneider MR, Michna H, el Etreby MF.
    J Steroid Biochem; 1989 Nov; 34(1-6):435-7. PubMed ID: 2533949
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.